Posts By Alex
530Wire StoriesImmuneOncia Announces Phase 1 Results of CD47 Antibody at ESMO 2023
SEOUL, South Korea–(BUSINESS WIRE)–ImmuneOncia (CEO Heung Tae Kim) announced the results of its Phase 1a solid tumour clinical trial (IMC-002-K102 Study) of...
- 479Wire Stories
Eli Israeli Joins Odysight.ai as Chief Technology Officer
OMER, Israel, Oct. 23, 2023 (GLOBE NEWSWIRE) — Odysight.ai Inc. (OTCQB: SCTC), a leading provider of visual based predictive maintenance (PdM) and...
- 439Wire Stories
Nighthawk Gold Delivers Inaugural ESG Report
TORONTO–(BUSINESS WIRE)–$MIMZF #esg—Nighthawk Gold Corp. (“Nighthawk†or the “Companyâ€) (TSX: NHK; OTCQX: MIMZF) delivers its Inaugural Environmental, Social, and Governance (“ESGâ€) Report,...
- 526Wire Stories
Alipay+ partners LankaPay to enhance digital travel experience to and from Sri Lanka
More than 400,000 merchants in Sri Lanka will be able to accept cross-border digital payments from some of Asia’s most popular digital...
- 517Wire Stories
SkyDrive Selected for Innovation Grant Worth up to 12.4 Billion Yen by Japanese Government
TOYOTA, Japan–(BUSINESS WIRE)–#FlyingCars–SkyDrive Inc. (“SkyDriveâ€), a leading Japanese eVTOL aircraft (*1) manufacturer based in Japan, is pleased to announce that it has...
- 449Wire Stories
Fearless, Solid and Reliable, DONGFENG KC Ushers a New Journey in the World
WUHAN, China–(BUSINESS WIRE)–Customer-oriented, in response to the dominance of road transport in many regions around the world, Dongfeng Commercial Vehicles launched new...
- 425Wire Stories
HighField Biopharmaceuticals Announces Positive Phase 1a Data of HF1K16, a new Immuno-Oncology Drug, For Patients with Recurrent and Refractory Glioma
HighField CEO Yuhong Xu and CBO Donald Wyatt are attending BIO-Europe, November 6 – 8, 2023 to discuss these significant early results...
- 535Wire Stories
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
First market approval for Genexine discovered and developed therapeutic drug, Efesa (Efepoetin alfa), a long-acting erythropoietin (EPO) for the treatment of Chronic...
- 489Wire Stories
National Football League Teams Up with SES for Game Content Distribution
In a renewed partnership, SES’s hybrid distribution network to enable the NFL to reach over 35 partners in Europe, Asia and the...
- 449Wire Stories
Celltrion, Inc. & Celltrion Healthcare Co., Ltd. Announce Shareholders Approval of Merger
On October 23rd, at the EGM of shareholders, the merger agreement between Celltrion, Inc. & Celltrion Healthcare Co., Ltd. was approved Celltrion...
